Enhance drug safety with advanced pharmacovigilance using big data, machine learning, and QSAR predictions.
Digital Transformation
The New ICH E6 (R3) Guidelines: Impact on Clinical Trials
In anticipation of the new ICH GCP E6(R3) guidelines, which are due to be implemented in August / September 2024, as Arithmos we would like to discuss the evolution of clinical trial designs and proportional risks.
Case Study | Arithmos Transforms Medical Device Company’s Data Landscape with a Data Warehouse Implementation
Explore, in this case study, how Arithmos helped a medical device company overcome data silos and fragmented data to achieve a single source of truth for informed decision-making.
Report | Pharmacovigilance 2.0: Leveraging Analytics and Automation
Read this report that summarises the insights from twenty pharmaceutical industry professionals working in IT and pharmacovigilance departments
eTMF Integration: Benefits and Impact on QMS
Improve efficiency, security, & data quality in clinical trials with eTMF integration. Learn how it impacts QMS & benefits of integrating with CTMS & EDC systems.
On Demand Webinar | Signal Detection: how innovation drives efficiency and effectiveness in PV processes
This webinar delves into challenges, with insights into how technology-enhanced solutions can revolutionise signal detection practices.
On Demand Webinar | Mastering Long-Term Clinical Data Retention: Strategies for Success
Join us in this new live webinar for a practical guide to digital archiving of clinical data and systems for long-term retention.
Arithmos attends the Veeva R&D and Quality Summit 2024
Join us in Madrid from the 4th – 5th of June to connect with our Life Science professionals and discuss your industry needs.
Case Study | Digital Innovation in Signal Detection
Read our case study on an innovative signal detection solution implementation for a large size pharmaceutical headquartered in Italy.
Whitepaper | Analysis of Future Trends and Technologies in Pharmacovigilance
In this Whitepaper, we analyse the current and future changes in the pharmacovigilance field, and how technology plays a critical role.
